Danaher Corporation (DAP.DE)

205,60 +4,10 (+2,03%) Börsenschluss: 05:35PM CET

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 79.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Steven M. Rales	Co-Founder & Chairman	N/A	N/A	1951
Mr. Rainer M. Blair	President, CEO & Director	5,5M	5,41M	1964
Mr. Mitchell P. Rales	Co-Founder & Director	N/A	N/A	1957
Mr. Matthew R. McGrew	CFO & Executive VP	2,65M	3,82M	1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Senior VP & Chief Science Officer	2,08M	N/A	1963
Mr. Joakim Weidemanis	Executive Vice President	2,91M	5,83M	1969
Mr. Christopher M. Bouda	VP & Chief Accounting Officer	N/A	N/A	N/A
Mr. John Bedford	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Brian W. Ellis	Senior VP, General Counsel & Chief Compliance Officer	1,79M	N/A	1967
Mr. Daniel A. Raskas J.D.	Senior Vice President of Corporate Development	N/A	N/A	1967

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Corporate Governance

Danaher Corporations ISS Governance QualityScore, Stand 1. Dezember 2023, lautet 7. Die grundlegenden Scores sind Audit: 8, Vorstand: 10, Shareholderrechte: 2, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.